Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Tarih
2021
Yazar
YUMUK, Volkan Demirhan
Siva, Zeynep Osar
Sahin, Humeyra Rekali
DAMCI, Taner
Ilkova, Hasan
Sahin, Serdar
Haliloglu, Ozlem
Korkmaz, Ozge Polat
DURCAN, Emre
Üst veri
Tüm öğe kaydını göster
Özet
Background/aim: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM).
Bağlantı
http://hdl.handle.net/20.500.12627/171632
https://doi.org/10.3906/sag-2008-37
Koleksiyonlar